EUVIMEDDécouvrir EUVIMED
EUVIMED · CrossrefJournal

Circulation: Arrhythmia and Electrophysiology

ISSN 1941-3149 · Ovid Technologies (Wolters Kluwer Health)

Latest articles

  1. Dynamic Risk Assessment of Severe Ventricular Arrhythmia in Patients With Implantable Defibrillators and Reduced Left Ventricular Ejection Fraction

    Jesús Diz-Díaz, José María Lillo-Castellano, Giulio La Rosa, Maeve Soto-Pérez, José Martínez-Ferrer, Enrique Ricoy, Alberto Barrera, Juan Gabriel Martínez, Juan Carlos Rodríguez-Pérez, Aníbal Rodríguez, Ignasi Anguera, Xavier Viñolas, Pablo Peñafiel, Moisés Rodríguez-Mañero, Ivo Roca-Luque, Andreu Porta-Sánchez, Javier Jiménez-Díaz, Juan Jiménez-Jáimez, Eva Cabrera, Luis Tercedor, Iván Hernández-Betancor, Sergio Castrejón, Carlos Álvarez-Ortega, José Luis Merino, Rafael Peinado, Victoria Cañadas-Godoy, Juan José González-Ferrer, María Salgado, David Calvo-Cuervo, Ricardo Salgado-Aranda, Alba Cruz, Manuel Marina-Breysse, María Jesús García-Torrent, Alba García-Escolano, Alba Ramos-Prada, Noemí Ramos-López, Julia Ramírez, Andrés Redondo-Rodríguez, Jorge G. Quintanilla, Silvia Priori

    Published: 2026-11-20DOI: 10.1161/circep.125.015093

  2. Characteristics of Recurrent Atrial Arrhythmias and Lesion Assessment Late After Pulsed Field Ablation of Atrial Fibrillation

    Maxime Beneyto, Corentin Chaumont, Masaaki Yokoyama, Franck Raczka, Olivier Thomas, Nathan Marimpouy, Mickael Laredo, William Escande, Sandrine Venier, Gregoire Massoulié, Matthieu Granier, Gabriel Decebal Latcu, Pierre Ollitrault, Laure Champ-Rigot, Leslie Placide, Pascal Defaye, Antoine Lepillier, Estelle Gandjbakhch, Serge Boveda, Pierre Jaïs, Frederic Anselme, Frederic Sacher, Philippe Maury

    Published: 2026-10DOI: 10.1161/circep.125.014506

  3. Atrial Fibrillation Ablation Effectiveness End Points, Safety End Points, and Trial Design: Academic Research Consortium Initiative Endorsed by the Heart Rhythm Society

    Paul J. Wang, Edward P. Gerstenfeld, Jonathan P. Piccini, Atul Verma, T. Jared Bunch, Carina Blomstrom-Lundqvist, Stylianos Tzeis, Jason G. Andrade, A. John Camm, Lin Yee Chen, Rod Passman, Matthew R. Reynolds, Hugh Calkins, Andrea M. Russo, Pierre Jais, Mina Chung, Boris Schmidt, Marco Perez, Elaine Y. Wan, Kevin L. Thomas, Eileen Mihas, Mellanie True Hills, J. Peter Weiss

    Published: 2026-10DOI: 10.1161/circep.126.015082

  4. Effect of Left Atrial Size and Volume Reduction on Pulmonary Vein Isolation Efficacy in Patients With Persistent and Longstanding Persistent Atrial Fibrillation: Subset Analysis From the aMAZE Trial

    Dhanunjaya Lakkireddy, David J. Wilber, Suneet Mittal, David Rene Tschopp, Christopher R. Ellis, Abdi Rasekh, Troy Hounshell, Robert Hoyt, Rudolph F. Evonich, Sheetal Chandhok, Ronald D. Berger, Rodney Horton, Michael Hoskins, Hugh Calkins, Steven J. Yakubov, Omar K. Khalique, Todd Cory Pulerwitz, Nitish Badhwar, Thomas Dewland, Stanislav Weiner, Smit Valsaiwala, Aashish Katapadi, Pamela Simons, Patrick Walker, Nifi Ndilkintum, Luigi DiBiase, Andrea Natale, Randall J. Lee, William Spear, Vijendra Swarup, Brian Deville, Peter Fail, William Spear, Erik Sirulnick, Anand Shah, Grant Simons, Miguel Valderrabano, Felix Yang, John Sturdivant, Timothy Mahoney

    Published: 2026-08DOI: 10.1161/circep.125.014755

  5. Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals

    Nada R. Abuknesha, James H O’Keefe, Frank Qian, Nathan L. Tintle, Yidie Lin, Yue Sun, Han-Zhu Qian, Paul S. Aisen, Christine M. Albert, William J. Aronson, Abdul Aziz A. Asbeutah, Heike A. Bischoff-Ferrari, Matthew J. Budoff, Nicholas R. Burns, Cecilia A. Cardenas, Cynthia M. Carlsson, Emily Y. Chew, Neal J. Cohen, Léopold K. Fezeu, Amana Liddell, Pilar Galan, Mark A. Hull, Tsuo-Hung Lan, Pan-Yen Lin, Alexia Mengelberg, Anne-Marie Minihane, Joseph F. Quinn, Thomas A.B. Sanders, Andrew Scholey, David A. Schoenfeld, Kirsty Sprange, Kuan-Pin Su, Christopher H. van Dyck, Carol A. Van Hulle, David Vauzour, Claire Weber, Francine K. Welty, Gary Wittert, William S. Harris

    Published: 2026-08DOI: 10.1161/circep.125.014785

Volumes

2026 · 1182025 · 1302024 · 1142023 · 922022 · 1052021 · 1422020 · 1822019 · 1702018 · 1862017 · 1972016 · 2012015 · 2342014 · 2142013 · 2122012 · 2052011 · 1672010 · 1002009 · 1102008 · 63

Des connaissances adaptées à votre travail.

D’un démarrage gratuit à la Research Suite complète, en passant par la recherche bibliographique personnelle.

Voir les tarifs →

Tous les textes intégraux sont-ils inclus ?

Non. Notices, résumés et textes intégraux sont des contenus distincts. La disponibilité dépend de la source, de l’accès ouvert et de vos licences. Une offre EUVIMED ne remplace pas des droits supplémentaires auprès des éditeurs.